{"id":"W4406687500","doi":"10.1093/ecco-jcc/jjae190.0894","title":"P0720 Cost-effectiveness of vedolizumab vs. ustekinumab as first-line biologic in treatment sequencing for ulcerative colitis in Canada","year":2025,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Takeda (Canada)","funders":"","keywords":"Vedolizumab; Medicine; Ustekinumab; Ulcerative colitis; Internal medicine; Gastroenterology; Crohn's disease; Tofacitinib; Dermatology; Infliximab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005130393,0.0011018,0.002197711,0.001930871,0.001476837,0.003137382,0.002465742,0.001498622,0.008115852],"category_scores_gemma":[0.02305358,0.000995404,0.00491972,0.00224755,0.0009835853,0.001135627,0.00137986,0.002225374,0.0002153811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.111902,"about_ca_system_score_gemma":0.08940824,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9710694,"about_ca_topic_score_gemma":0.9576426,"domain_scores_codex":[0.9958586,0.001991597,0.0002194857,0.0003993624,0.0005615882,0.0009692875],"domain_scores_gemma":[0.99042,0.005061795,0.001023565,0.0002418057,0.001892791,0.001360121],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03434898,0.00138872,0.1004124,0.004466621,0.01354916,0.0006731541,0.0003764963,0.7235462,0.0009116596,0.0242535,0.01691501,0.07915805],"study_design_scores_gemma":[0.0146309,0.003338036,0.07011548,0.001915815,0.01435103,0.0003876577,0.0009962136,0.8727671,0.001336593,0.01016121,0.009689211,0.0003108261],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9146996,0.02125804,0.009527652,0.008860963,0.0003560685,0.00322229,0.02193105,0.0002454855,0.01989893],"genre_scores_gemma":[0.9900993,0.001905505,0.003225124,0.000472668,0.00002668994,0.0002676022,0.002241272,0.00002542486,0.001736397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.111902,"threshold_uncertainty_score":0.8119095,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03199449956713621,"score_gpt":0.3149365162590643,"score_spread":0.2829420166919281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}